Accelerate Your Obesity Drug Development

If you are working on next-gen obesity therapies, you know how difficult it can be to assess potential clinical effects, including long-term weight management and weight rebound. With obesity affecting over one billion people worldwide, finding translationally relevant preclinical models has never been more important.

We’d like to invite you to our webinar on Nov 14, where our expert will demonstrate how our Diet-Induced Obesity (DIO) rodent models, combined with high-resolution phenotyping,  provide a translational bridge from preclinical research to human insights.

Webinar Details

• Date: November 14, 2025
• Time: 11 am EDT (NA) / 8 am PDT (NA) / 4 pm BST (UK) / 5 pm CEST (EU-Central)
• Speaker: John Liu Ph.D., Head of Pharmacology, BioDuro